Cargando…

The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma

In a blind, dual-center, multi-observer setting, we here identify the pre-treatment radiologic features by Magnetic Resonance Imaging (MRI) associated with subsequent treatment options in patients with glioma. Study included 220 previously untreated adult patients from two institutions (94 + 126 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Due-Tønnessen, Paulina, Pinho, Marco C., Emblem, Kyrre E., Hald, John K., Kanoto, Masafumi, Abildgaard, Andreas, Sederevicius, Donatas, Groote, Inge R., Rapalino, Otto, Bjørnerud, Atle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934740/
https://www.ncbi.nlm.nih.gov/pubmed/31882644
http://dx.doi.org/10.1038/s41598-019-56333-x
_version_ 1783483453787865088
author Due-Tønnessen, Paulina
Pinho, Marco C.
Emblem, Kyrre E.
Hald, John K.
Kanoto, Masafumi
Abildgaard, Andreas
Sederevicius, Donatas
Groote, Inge R.
Rapalino, Otto
Bjørnerud, Atle
author_facet Due-Tønnessen, Paulina
Pinho, Marco C.
Emblem, Kyrre E.
Hald, John K.
Kanoto, Masafumi
Abildgaard, Andreas
Sederevicius, Donatas
Groote, Inge R.
Rapalino, Otto
Bjørnerud, Atle
author_sort Due-Tønnessen, Paulina
collection PubMed
description In a blind, dual-center, multi-observer setting, we here identify the pre-treatment radiologic features by Magnetic Resonance Imaging (MRI) associated with subsequent treatment options in patients with glioma. Study included 220 previously untreated adult patients from two institutions (94 + 126 patients) with a histopathologically confirmed diagnosis of glioma after surgery. Using a blind, cross-institutional and randomized setup, four expert neuroradiologists recorded radiologic features, suggested glioma grade and corresponding confidence. The radiologic features were scored using the Visually AcceSAble Rembrandt Images (VASARI) standard. Results were retrospectively compared to patient treatment outcomes. Our findings show that patients receiving a biopsy or a subtotal resection were more likely to have a tumor with pathological MRI-signal (by T2-weighted Fluid-Attenuated Inversion Recovery) crossing the midline (Hazard Ratio; HR = 1.30 [1.21–1.87], P < 0.001), and those receiving a biopsy sampling more often had multifocal lesions (HR = 1.30 [1.16–1.64], P < 0.001). For low-grade gliomas (N = 50), low observer confidence in the radiographic readings was associated with less chance of a total resection (P = 0.002) and correlated with the use of a more comprehensive adjuvant treatment protocol (Spearman = 0.48, P < 0.001). This study may serve as a guide to the treating physician by identifying the key radiologic determinants most likely to influence the treatment decision-making process.
format Online
Article
Text
id pubmed-6934740
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69347402019-12-30 The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma Due-Tønnessen, Paulina Pinho, Marco C. Emblem, Kyrre E. Hald, John K. Kanoto, Masafumi Abildgaard, Andreas Sederevicius, Donatas Groote, Inge R. Rapalino, Otto Bjørnerud, Atle Sci Rep Article In a blind, dual-center, multi-observer setting, we here identify the pre-treatment radiologic features by Magnetic Resonance Imaging (MRI) associated with subsequent treatment options in patients with glioma. Study included 220 previously untreated adult patients from two institutions (94 + 126 patients) with a histopathologically confirmed diagnosis of glioma after surgery. Using a blind, cross-institutional and randomized setup, four expert neuroradiologists recorded radiologic features, suggested glioma grade and corresponding confidence. The radiologic features were scored using the Visually AcceSAble Rembrandt Images (VASARI) standard. Results were retrospectively compared to patient treatment outcomes. Our findings show that patients receiving a biopsy or a subtotal resection were more likely to have a tumor with pathological MRI-signal (by T2-weighted Fluid-Attenuated Inversion Recovery) crossing the midline (Hazard Ratio; HR = 1.30 [1.21–1.87], P < 0.001), and those receiving a biopsy sampling more often had multifocal lesions (HR = 1.30 [1.16–1.64], P < 0.001). For low-grade gliomas (N = 50), low observer confidence in the radiographic readings was associated with less chance of a total resection (P = 0.002) and correlated with the use of a more comprehensive adjuvant treatment protocol (Spearman = 0.48, P < 0.001). This study may serve as a guide to the treating physician by identifying the key radiologic determinants most likely to influence the treatment decision-making process. Nature Publishing Group UK 2019-12-27 /pmc/articles/PMC6934740/ /pubmed/31882644 http://dx.doi.org/10.1038/s41598-019-56333-x Text en © The Author(s) 2019, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Due-Tønnessen, Paulina
Pinho, Marco C.
Emblem, Kyrre E.
Hald, John K.
Kanoto, Masafumi
Abildgaard, Andreas
Sederevicius, Donatas
Groote, Inge R.
Rapalino, Otto
Bjørnerud, Atle
The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
title The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
title_full The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
title_fullStr The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
title_full_unstemmed The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
title_short The Impact of MRI Features and Observer Confidence on the Treatment Decision-Making for Patients with Untreated Glioma
title_sort impact of mri features and observer confidence on the treatment decision-making for patients with untreated glioma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934740/
https://www.ncbi.nlm.nih.gov/pubmed/31882644
http://dx.doi.org/10.1038/s41598-019-56333-x
work_keys_str_mv AT duetønnessenpaulina theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT pinhomarcoc theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT emblemkyrree theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT haldjohnk theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT kanotomasafumi theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT abildgaardandreas theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT sedereviciusdonatas theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT grooteinger theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT rapalinootto theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT bjørnerudatle theimpactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT duetønnessenpaulina impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT pinhomarcoc impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT emblemkyrree impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT haldjohnk impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT kanotomasafumi impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT abildgaardandreas impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT sedereviciusdonatas impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT grooteinger impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT rapalinootto impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma
AT bjørnerudatle impactofmrifeaturesandobserverconfidenceonthetreatmentdecisionmakingforpatientswithuntreatedglioma